/index.php?option=com_iwpfile&file=/dir_01/he2002_1180.pdf


/index.php?option=com_iwpfile&file=/dir_01/he2002_1176.pdf


ma

February 19, 2002

Media Inquiries: 301-827-6242

Consumer Inquiries: 888-INFO-FDA

FDA today approved a novel treatment regime for one type of non-Hodgkins Lymphoma (NHL) that for the first time includes a monoclonal antibody that is combined with a radioactive chemical. The product, Zevalin, must be used along with Rituxan, an already approved biotechnology product for the disease -- low-grade B-cell NHL. It is approved for patients who have not responded to standard chemotherapy treatments or to the use of Rituxan alone.



In Nursing Homes

M E M O R A N D U M

To: Reporters and Editors

Fr: Jill Gerber, 202/224-6522

Re: nursing home staffing

Da: Wednesday, Feb. 20, 2002



hy

MEDICARE TO EXPAND USE OF PET FOR PATIENTS WITH HEART DISEASE

The Centers for Medicare & Medicaid Services (CMS) announced today that it intends to cover positron emission tomography (PET) for use in determining whether certain Medicare patients are good candidates for revascularization -- procedures to improve blood flow to the heart.

A national coverage decision to be issued by CMS will make PET available as a primary or initial diagnostic study for determining myocardial viability in patients with ischemic heart disease.



ar

February 18, 2002

FAIRNESS FOR DOCTORS A MUST, JOHNSON SAYS

Physician Reimbursement in Medicare a Top Priority

Connecticut Medical Society Backs Johnson Effort



on Between CMS And FDA

For Immediate Release

February 12, 2002

CONTACT: Bradley Merrill Thompson

317.569.4637

IMDMC Announces 2002 Medicare Policy Agenda

Modernization, Coverage, Responsiveness Top List

WASHINGTON, D.C. The Indiana Medical Device Manufacturers Council, known as "IMDMC," today announced a 2002 Medicare policy agenda focused on speeding patient access to quality-enhancing medical innovations.



/index.php?option=com_iwpfile&file=/dir_01/he2002_1169.pdf


ly Click here for Summary of Nursing Home Study Click here


The following files are all available in PDF format. Simply click on the link to download the file.



Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.